Table 2.
Characteristics | Nr. | (%) |
---|---|---|
All cases | 80 | |
Age, median (range), years | 59 (30–84) | |
FIGO stage | ||
III c | 55 | 69 |
IV | 25 | 31 |
Ascites | ||
Yes | 22 | 27.5 |
No | 58 | 72.5 |
Histology | ||
Serous | 44 | 55 |
Endometrioid/clear cells | 12 | 15 |
Mucinous | 8 | 10 |
Other adenocarcinoma | 16 | 20 |
PCI, median (range) | 12 (2–35) | |
PCI 1–10 | 34 | 42.5 |
PCI 11–20 | 25 | 31.2 |
PCI > 20 | 21 | 26.2 |
Duration of surgery, median (range) | 360 (60–638) | |
Residual tumor | ||
CCS | 64 | 80 |
OCS | 5 | 6.2 |
SCS | 11 | 13.8 |
PCI peritoneal carcinomatosis index, CCS complete cytoreductive surgery, OCS optimal cytoreductive surgery, SCS suboptimal cytoreductive surgery